ArticleClinical and experimental immunology2016

Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions.

A Vultaggio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.